The DOI matches its Crossref record.
Sustained Release and Standard Methylphenidate Effects on Cognitive and Social Behavior in Children With Attention Deficit Disorder
Abstract
Two studies were conducted to investigate the relative effects of sustained release methylphenidate (Ritalin [SR-20]) and standard methylphenidate (Ritalin, 10 mg, administered twice daily). In the first study, 13 boys with attention deficit disorder participating in a summer treatment program went through a double-blind, within-subject trial of each form of methylphenidate and placebo. Measures of social and cognitive behavior were gathered in classroom and play settings. Although group analyses of the data showed that both drugs were effective and there were few differences between them, standard methylphenidate was superior to SR-20 on several important measures of disruptive behavior. Furthermore, analyses of individual responsivity showed clearly that most boys responded more positively to standard methylphenidate than to SR-20. The second study involved a partially overlapping group of nine boys with attention deficit disorder participating in the same summer treatment program. Also double-blind, within-subject, and placebo controlled, this study tracked the time courses of the two forms of methylphenidate. Both were shown to have similar time courses on the Abbreviated Conners Rating Scale and other measures, but SR-20 had a slower onset than did the standard drug form on a continuous performance task. Effects of SR-20 were still evident eight hours after ingestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, the short duration of action of available stimulants necessitates multiple daily doses for many children to provide effective symptom management (Pelham et al., 1987;Swanson et al., 1978).”
From Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, SLI381 (ADDERALL XR), in Children With ADHD (2003) · cites this paper as Pelham et al., 1987
Citations
Cited by
Sorted by citations
Items 101–170 of 170
The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD
Childress, A. C., & Sallee, F. R. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.833002 · Cited by 26
Preliminary Findings of an Early Intervention Program with Aggressive Hyperactive Children
Barkley, R. A., Shelton, T. L., Crosswait, C., Moorehouse, M., Fletcher, K. E., Barrett, S., JENKINS, L., & Metevia, L. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32528.x · Cited by 26
Managing Stimulant Medication for Attention-deficit/Hyperactivity Disorder
Wender, E. H. (2001) · Pediatrics in Review · doi:10.1542/pir.22-6-183 · Cited by 26
Kollins, S. H., Barkley, R. A., & DuPaul, G. J. (2017) · Focus on Exceptional Children · doi:10.17161/foec.v33i5.6779 · Cited by 25
Langzeitwirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen
Döpfner, M., Banaschewski, T., Schmidt, J., Uebel, H., Schmeck, K., Gerber, W. D., Gunter, M. M., Knölker, U., Gehrke, M., Häßler, F., et al. (2003) · Nervenheilkunde · doi:10.1055/s-0038-1624375 · Cited by 25
The Use of Methylphenidate for Cognitive Decline Associated with HIV Disease
Brown, G. R. (1995) · The International Journal of Psychiatry in Medicine · doi:10.2190/72u2-fq94-rvk5-6j5c · Cited by 25
(1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199105000-00038 · Cited by 25
Lee, L., Kepple, J., Wang, Y., et al. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.358 · Cited by 24
Wang, Y., Lee, L., Somma, R., Thompson, G., Bakhtiar, R., Lee, J., Rekhi, G. S., Lau, H. S. H., Sedek, G., & Hossain, M. S. (2004) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.390 · Cited by 23
“While modified-release formulations of MPH were developed to alleviate the need for multiple daily dosing, the onset of action of these formulations is perceived to be slow, and they do not appear to be as clinically effective as the immediate-release formulations given twice per day [5,6].”
BackgroundWilens, T. E., & Spencer, T. J. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_31 · Cited by 27
Kaiser, N. M., Hoza, B., Pelham, W. E., Gnagy, E. M., & Greiner, A. R. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707311661 · Cited by 22
Self-citationA Postmarketing Clinical Experience Study of Metadate® CD
Dirksen, S. J. H., D'Imperio, J. M., Birdsall, D., & HATCH, S. J. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001100 · Cited by 20
“IR MPH 0–20 mg (n = 24) > 20–40 mg (n = 29) > 40 mg (n = 13) 20 (87) 10 (37) 0 3 (13) 15 (56) 4 (33) 0 (0) 2 (7) 8 (67)”
Primer consenso latinoamericano de trastorno por déficit de atención e hiperactividad
Barragán-Pérez, E., de la Peña, F. R., León, S. O., Ruíz-Garcìa, M., Hernández-Aguilar, J., Palacios‐Cruz, L., & Suárez-Reynaga, A. (2007) · Boletín Médico del Hospital Infantil de México · Cited by 17
Effect on Dissolution from Halving Methylphenidate Extended-Release Tablets
Erramouspe, J., & Jarvi, E. J. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101001 · Cited by 18
Predictive value of placebo methylphenidate
Tirosh, E., Elhasid, R., Kamah, S. C.-B., et al. (1993) · Pediatric Neurology · doi:10.1016/0887-8994(93)90049-i · Cited by 17
Attention-deficit Hyperactivity Disorder in Children and Adolescents
Conners, C. K., & Erhardt, D. (1998) · Elsevier eBooks · doi:10.1016/b0080-4270(73)00133-4 · Cited by 20
Greenhill, L. L. (1992) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30596-0 · Cited by 16
Barkley, R. A., DuPaul, G. J., & Costello, A. J. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2884-5_8 · Cited by 16
Psychostimulants in Attention Deficit Hyperactivity Disorder
Connor, D. F. (2005) · Contemporary clinical neuroscience · doi:10.1385/1-59259-891-9:487 · Cited by 15
Clinical Management of Attention Deficit Hyperactivity Disorder
Voeller, K. K. S. (1991) · Journal of Child Neurology · doi:10.1177/0883073891006001s07 · Cited by 14
Review and Comparison of the Long Acting Methylphenidate Preparations
Liu, F., Muniz, R., Minami, H., & Silva, R. R. (2005) · Psychiatric Quarterly · doi:10.1007/s11126-005-2979-0 · Cited by 13
Block, S. L. (1998) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70062-6 · Cited by 15
Treatment of Adhd in Children and Adolescents
Wells, K. C. (2004) · Wiley eBooks · doi:10.1002/9780470753385.ch15 · Cited by 13
Sinzig, J., Döpfner, M., Plück, J., Banaschewski, T., Stephani, U., Lehmkuhl, G., Rothenberger, A., & Methylphenidat, A. (2004) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.32.4.225 · Cited by 12
Current Approaches to Management of Attention Deficit Hyperactivity Disorder
Jarman, F. C. (1996) · The Australian Educational and Developmental Psychologist · doi:10.1017/s0816512200027395 · Cited by 12
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E. J. S., Bet, P. M., & Oosterlaan, J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000671 · Cited by 11
Attention deficit hyperactivity disorder in children: Diagnosis, treatment, and follow-up
Murphy, M. A., & Hagerman, R. J. (1992) · Journal of Pediatric Health Care · doi:10.1016/0891-5245(92)90059-d · Cited by 11
Barkley, R. A., DuPaul, G. J., & Connor, D. F. (1999) · Springer eBooks · doi:10.1007/978-1-4899-0086-9_8 · Cited by 11
Lee, S., Choi, J.-W., Kim, K.-M., Kim, J. W., Kim, S.-Y., Kang, T.-W., Kim, J. I., Lee, Y. S., Kim, B., Han, D. H., et al. (2016) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2016.27.4.236 · Cited by 10
The medical management of attention-deficit / hyperactivity disorder: spoilt for choice?
Venter, A. R. (2006) · African Journal of Psychiatry · doi:10.4314/ajpsy.v9i3.30215 · Cited by 9
Attention-Deficit Hyperactivity Disorder
Mandelbaum, D. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00047-0 · Cited by 9
Faraone, S. V., Goméni, R., Hull, J. T., Busse, G. D., Lujan, B., Rubin, J. S., & Nasser, A. F. (2023) · Brain and Behavior · doi:10.1002/brb3.2910 · Cited by 7
“Pelham et al. (1987) compared the effects of sustained-release MPH and IR MPH on social behavior in children with ADHD attending a summer camp program, wherein both drugs improved social behaviors and exhibited similar time courses of onset (Pelham et al., 1987).”
Attention deficit/hyperactivity disorder: pharmacotherapy.
Elia, J. (2005) · PubMed Central · Cited by 9
Attention-Deficit/Hyperactivity Disorder: Diagnosis and Treatment
REIFF, M. I., & Stein, M. T. (2004) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00043-9 · Cited by 8
Treatment Issues in Children with Attention-Deficit Hyperactivity Disorder
Greenhill, L. L. (1989) · Psychiatric Annals · doi:10.3928/0048-5713-19891101-10 · Cited by 8
Pharmacological Treatment of Attention-Deficit/HyperactivityDisorder
Schachar, R. J., & Ickowicz, A. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4881-2_10 · Cited by 8
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Sevecke, K., Döpfner, M., & Lehmkuhl, G. (2004) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.32.4.265 · Cited by 7
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Darling, P. J., Huus, C.-M. L., Zwi, M., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub4 · Cited by 10
Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder
Feldman, H. M., Pierce, K., Wolraich, M. L., Brown, R. T., Amler, R. W., Freeman, W., & Perrin, J. M. (2007) · Cited by 6
Attention Deficit Hyperactivity Disorder
Lin‐Dyken, D. C., & Wolraich, M. L. (1992) · Springer eBooks · doi:10.1007/978-1-4612-2774-8_13 · Cited by 9
Introduction to the Special issue: Child Psychopharmacology
Barkley, R. A. (1991) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2003_1 · Cited by 5
Kollins, S. H., Barkley, R. A., & DuPaul, G. J. (2017) · Focus on Exceptional Children · doi:10.17161/fec.v33i5.6779 · Cited by 4
Yoo, H. K., Kim, B.-S., Joung, Y., Bahn, G. H., Song, D., Ahn, D.-H., & Lee, Y.-S. (2011) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2011.22.4.253 · Cited by 3
Attention-deficit/hyperactivity disorder: Focus on pharmacologic management
Reitz, S. J. (1997) · Journal of Pediatric Health Care · doi:10.1016/s0891-5245(97)90005-5 · Cited by 3
Effect of Formulation on Methylphenidate Release Patterns
Pentikis, H. S., & lez, M. A. G. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503010-00005 · Cited by 3
Kaiser, N. M., Hoza, B., Pelham, W. E., et al. (2008) · Journal of Attention Disorders · doi:10.1177/108705470801200301 · Cited by 3
Self-citationAttention Deficit Disorder and Hyperactivity
Gadow, K. D. (1988) · Applied clinical psychology · doi:10.1007/978-1-4613-0983-3_10 · Cited by 3
Childress, A. C., Belchenko, D. D., & Lempa, B. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1271714 · Cited by 2
“Although it has a longer duration of efficacy, it does not appear to be as effective as MPH-IR [12].”
BackgroundReséndiz-Aparicio, J. C., Barragán-Pérez, E., Dayán-Nahman, A., Ceja-Moreno, H., Ruíz-Garcìa, M., Garza-Morales, S. J., Cáceres-Vargas, M., Lara-Muñoz, C., Rodríguez-Rodríguez, E., Báez, L. M., et al. (2005) · Boletín Médico del Hospital Infantil de México · Cited by 2
A new treatment option for attention deficit/hyperactivity disorder
Starr, H. L. (2004) · Paediatrics & Child Health · doi:10.1093/pch/9.suppl_b.13b · Cited by 2
Dulcan, M. K. (1994) · Springer eBooks · doi:10.1007/978-1-4757-0345-0_23 · Cited by 2
Flake, R. A. (2013) · UKnowledge (University of Kentucky) · Cited by 1
Bolinger, A. M., Murphy, V. A. S., & Bubica, G. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_77 · Cited by 1
Bader, M., Junier, L., Ansermet, F., & Halfon, O. (2004) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2004.01511 · Cited by 1
Hishikawa, Y. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_15 · Cited by 1
Advances in Pediatric Pharmacology and Toxicology
Berlin, C. M. (1989) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00147-6 · Cited by 1
Nicotine Effects on Attention Deficit Hyperactivity Disorder
Levin, E. D. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch13 · Cited by 1
Los trastornos por conductas perturbadoras en relación con ciertas psicopatologías adultas
Yribas, C. H. (1993) · TDX (Tesis Doctorals en Xarxa)
Rubio‐Terres, C., Rubio-Rodríguez, D., & Molinero, C. (2012) · PharmacoEconomics Spanish Research Articles · doi:10.1007/bf03320877
The effects of medication on memory in children diagnosed with ADHD
Dunagan, B. J. (2011) · Digital Commons - George Fox University (George Fox University)
Review of Long-Acting Stimulant and Nonstimulant ADHD Pharmacotherapy in Canada
Weiss, M. D., Childress, A. C., Pucci, M. L., & Hechtman, L. T. (2010)
Swanson, V. C. (1999) · doi:10.31390/gradschool_disstheses.7018
“, 19 88), and a few studies have targeted social skills with peers (Pelham et al., 1987; Hinshaw, Henker, Whalen, Erhardt, & Dunnington, 1989; Gulley & Northup, 1997; Northup, Jones et al., 1997).”
BackgroundThe effect of ADHD on self-esteem in middle childhood
Peneder, P. (1998) · ANU Open Research (Australian National University) · doi:10.25911/5d690540bf73b
Vanderah, K. M. (1997) · UNI ScholarWorks (University of Northern Iowa)
ROSENBERG, D. R. (2002) · CRC Press eBooks · doi:10.1201/9780203909294.pt2
Childress, A. C. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp268
(2000) · Time to knit · doi:10.1016/s1885-9062(09)32008-4
Coles, E. K. (2025) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2025.2521851
“…to understanding ADHD, medication, behavioral treatments, combined interventions, and sequencing of treatment (e.g., Pelham & Hoza, 1996; Pelham et al., 1987, 2000), STP sites have also provided training in state-of-the art behavior modification strategies for treating ADHD and other…”
Metadata
- Authors
- Pelham, W. E., Sturges, J., Hoza, J., Schmidt, C., Bijlsma, J. J., Milich, R., & Moorer, S.
- Affiliations
- Florida State University (US)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1987-10-01
- Volume
- 80
- Issue
- 4
- Pages
- 491-501
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2158421224
- Cited by
- 167
- References
- 0
- Citations by year
- 2025: 2 · 2023: 2 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 5 · 2013: 5 · 2012: 5
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- methylphenidate, attention deficit disorder, children, cognitive behavior, social behavior, disruptive behavior, drug formulation comparison, time course of drug effects, continuous performance test, Conners rating scales, summer treatment program
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Cognition, Delayed-Action Preparations, Double-Blind Method, Humans, Male, Methylphenidate, Random Allocation, Social Behavior, Task Performance and Analysis, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review